Search

everythinglearnresearchcommunity

for

Search:↓

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Early diagnosis and quick treatment improve life quality for FFA patients.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Oral tofacitinib successfully treated total body hair loss in one patient.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.